References
- Bernini L. F., Harteveld C. L. α-Thalassaemia, Sickle Cell Disease and Thalassaemia. Bailliere's Clinical Haematology, G. P. Rodgers. Harcourt Brace Publishers International, LondonEngland 1998; Vol. 11: 53–90, 1
- Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215
- Kanavakis E., Tzotzos S., Liapaki A., Metaxotou-Mavromati A., Kattamis C. Frequency of a-thalassemia in Greece. Am. J. Hematol. 1986; 22: 225–232
- Papassotiriou I., Traeger-Synodinos J., Kanavakis E., Karagiorga M., Stamoulakatou A., Kattamis C. Erythroid marrow activity and hemoglobin levels in Hemoglobin H disease. J. Pediatr. Hematol. Oncol. 1998; 20: 539–544
- Traeger-Synodinos J., Kanavakis E., Tzetis M, Kattamis A., Kattamis C. Characterization of non-deletion a-thalassemia mutations in the Greek population. Am. J. Hematol. 1993; 44: 162–167
- Dodé C., Rochette J., Krishnamoorthy R. Locus assignment of human α-globin mutations by selective amplification and direct sequencing. Br. J. Haematol. 1990; 76: 275–281
- Hultman T., Ståhl S., Homes E., Uhlen M. Direct solid phase sequencingof genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res. 1989; 17: 4937–4946
- Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 1977; 74: 5463–5467
- Harteveld C. L., Losekoot M., Heister J. G.A.M., v.d. Wielen M., Giordano P. C., Bernini L. F. α-Thalassemia in The Netherlands: a heterogeneous spectrum of both deletions and point-mutations. Hum. Genet. 1997; 100: 465–471
- Pressley L., Higgs D. R., Clegg J. B., Weatherall D. J. Gene deletions in α-thalassemia prove that the 5″ is functional. Proc. Natl. Acad. Sci. USA 1980; 77: 3586–3589
- Goossens M., Lee K. J., Liebhaber S. A., Kan Y. W. Globin structural mutant α 125 Leu←Pro is a novel cause of a-thalassemia. Nature 1982; 296: 864–865
- Harteveld C. L., Giordano P. C., Losekoot M., Heister J. G.A.M., Batelaan D., Bruin M. C.A., Bernini L. F. Hb Utrecht [α2129(H12)Leu←Pro], a new unstable α2-chain variant associated with a mild a-thalassaemic phenotype. Br. J. Haematol. 1996; 94: 483–485
- Ayala S., Colomer D., Gelpí J. L., Vives Corrons J. L. α-Thalassaemia due to a single codon deletion in the α 1 globin gene. Computational structural analysis of the new α-chain variant. Hum. Mutat, (Mutation in Brief 132) 1997
- Huisman T. H.J., Carver M. F.H., Efremov G. D. A Syllabus of Human Hemoglobin Variants (SecondEdition). The Sickle Cell Anemia Foundation, Augusta, GAUSA 1998
- Cooper D. N., Krawczak M., Antonarakis S. E. The nature and mechanisms of human gene mutation. The Metabolic and Molecular Basis of Inherited Disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. McGraw-Hill, Inc., New York, NYUSA 1995; 259–291
- Streisinger G., Okada Y., Emrich J., Newton J., Tsugita A., Terzaghi E., Inouye M. Frameshift mutations and the genetic code. Cold Spring Harbor Symposium, Cold Spring Harbor, NY, USA. Quant. Biol. 1966; 31: 77–84
- Levinson G., Gutman G. A. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol. 1987; 4: 203–221
- Ripley L. S. Model for the participation of quasi-palindromic DNA sequences in frameshift mutation. Proc. Natl. Acad. Sci. USA 1982; 79: 4128–4132
- Krawczak M., Cooper D. N. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum. Genet. 1991; 86: 425–441
- Perutz M. F. Molecular anatomy, physiology and pathology of hemoglobin. The Molecular Basis of Blood Diseases, G. Stamatoyannopoulos, A. W. Nienhuis, P. Leder, P. W. Majerus. W.B. Saunders Company, Philadelphia, PAUSA 1987; 127–178
- Perutz M. F., Pulsinelli P. D., Ranney H. M. Structure and subunit interaction of Haemoglobin Milwaukee. Nature New Biol. 1972; 237: 259–263
- Wilson J. B, Webber B. B., Kutlar A., Reese A. L., McKie V. C., Lutcher C. L., Felice A. E., Huisman T. H.J. Hb Evans or α262(E11)Val Metβ2; an unstable hemoglobin causing a mild hemolytic anemia. Hemoglobin 1989; 13: 557–566